Connection

Jean-Marc Rolain to Pneumonia, Viral

Back to Details
This is a "connection" page, showing publications Jean-Marc Rolain has written about Pneumonia, Viral.
Jean-Marc Rolain
Connection Strength
0.120
Pneumonia, Viral
  1. Teicoplanin: an alternative drug for the treatment of COVID-19? Int J Antimicrob Agents. 2020 Apr; 55(4):105944.
    View in: PubMed
    Score: 0.028
  2. COVID-19 Therapeutic and Prevention. Int J Antimicrob Agents. 2020 04; 55(4):105937.
    View in: PubMed
    Score: 0.028
  3. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
    View in: PubMed
    Score: 0.007
  4. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect. 2020 Jun; 53(3):425-435.
    View in: PubMed
    Score: 0.007
  5. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
    View in: PubMed
    Score: 0.007
  6. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microb Pathog. 2020 Aug; 145:104228.
    View in: PubMed
    Score: 0.007
  7. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
    View in: PubMed
    Score: 0.007
  8. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949.
    View in: PubMed
    Score: 0.007
  9. SARS-CoV-2: fear versus data. Int J Antimicrob Agents. 2020 May; 55(5):105947.
    View in: PubMed
    Score: 0.007
  10. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 May; 55(5):105938.
    View in: PubMed
    Score: 0.007
  11. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents. 2020 04; 55(4):105933.
    View in: PubMed
    Score: 0.007
  12. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 04; 55(4):105932.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.